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Hypofunction of the serotonergic system is often associated with major depression and obsessive compulsive disorder (OCD). Selective
serotonin reuptake inhibitors (SSRIs) are commonly prescribed to treat these disorders, and require 3–6 weeks of chronic treatment
before improvements in the symptoms are observed. SSRIs inhibit serotonin’s transporter, and in doing so, increase extracellular
serotonin concentrations. Thus, efficacy of SSRIs likely depends upon the brain’s adaptive response to sustained increases in serotonin
levels. Individual responsiveness to SSRI treatment may depend on a variety of factors that influence these changes, including ongoing
stress. Social isolation is a passive, naturalistic form of chronic mild stress that can model depression in rodents. In this study, we examined
how 20-day treatment with the SSRI citalopram (CIT) alters marble-burying (MB), open field behavior, and serotonin signaling in single- vs
pair-housed animals. We used in vivo voltammetry to measure electrically evoked serotonin, comparing release rate, net overflow, and
clearance. Pair-housed mice were significantly more responsive to CIT treatment, exhibiting reduced MB and facilitation of serotonin
release that positively correlated with the frequency of electrical stimulation. These effects of CIT treatment were attenuated in single-
housed mice. Notably, although CIT treatment enhanced serotonin release in pair-housed mice, it did not significantly alter uptake rate. In
summary, we report that chronic SSRI treatment facilitates serotonin release in a frequency-dependent manner, and this effect is blocked
by social isolation. These findings suggest that the efficacy of SSRIs in treating depression and OCD may depend on ongoing stressors
during treatment.





















































Disorders involving depression and anxiety, including major
depression and obsessive compulsive disorder (OCD), have
high rates of comorbidity and are frequently attributed to
hypofunction of the serotonergic system (Bespalov et al,
2010; Jacobsen et al, 2012). The most commonly prescribed
medications in the treatment of depression and OCD are
selective serotonin reuptake inhibitors (SSRIs), which
inhibit serotonin’s transporter (SERT). Acute SERT inhibi-
tion increases brain-wide serotonin levels and depresses
firing of serotonergic neurons (Blier and de Montigny,
1998a). Clinically, 3–6 weeks of continuous SSRI treatment
are required before symptoms of depression and OCD begin
to improve (de Montigny et al, 1992). This gap between
treatment onset and therapeutic response suggests that the
mechanism by which SSRIs exert antidepressive and
anxiolytic effects is not only due to an increase in ambient
serotonin, but also due to an adaptive response in neural
systems to sustained increases in serotonin levels. Indeed, a
multitude of changes in gene expression, receptor sensiti-
vity, neurochemical signaling, and functional activity
coincide with the therapeutic window of SSRI therapy
(Bespalov et al, 2010; Blier and de Montigny, 1998a; de
Montigny et al, 1992).
Although it is common to treat depression and OCD with
SSRIs, the effectiveness of the treatment is also notoriously
variable between individuals. Reports estimate that over
60% of depressed individuals and 40–60% of individuals
with OCD are resistant to improvement while on SSRI
therapy (Brandl et al, 2012; Gaynes et al, 2008). Depressed
individuals with comorbid anxiety disorders have poorer
outcomes on all types of antidepressant medication when
compared with non-anxious depressed individuals (Fava
et al, 2008). The serotonergic system is highly sensitive to
stress, and genetic variability in its function contributes to
stress resilience and responsiveness to SSRI therapy
(Chaouloff et al, 1999; Oreland et al, 2010; Uher, 2011).
Clinical research suggests that ongoing stress, including
the absence of social support networks, can contribute to
treatment-resistant depression and anxiety (Karelina and
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DeVries, 2011). Thus, improving pharmacotherapies for
depression and OCD will likely require an understanding of
how stress and anxiety interact with SSRI treatments. Social
isolation is a form of chronic mild stress that replicates
naturalistic environmental stressors for rodents, and has
been suggested as an animal model for depressive disorders
(Nestler and Hyman, 2010; Wiborg, 2013). In mice, social
isolation significantly upregulates the function of the
hypothalamic-pituitary-adrenal (HPA) axis, altering levels
of glucocorticoid (CORT) and corticotropin releasing factor
(CRF) in various brain regions (Backstrom and Winberg,
2013; Blanchard et al, 2001; Valzelli, 1973). The HPA axis
also regulates serotonin signaling and the effects of anti-
depressants (Barden, 1996, 2004; Pariante and Miller, 2001).
Understanding how ongoing social isolation alters seroto-
nin signaling in mice, particularly in response to SSRIs, may
provide clues about how stress influences treatment-
resistant depression and OCD.
SSRI treatment changes serotonin metabolism, receptors,
and transporters in ways that could facilitate serotonergic
activity. However, prior to this work, the effects of chronic
SSRIs on endogenous in vivo serotonin release and uptake
have not been reported. We used fast-scan cyclic voltam-
metry (FSCV) to monitor serotonin signaling and altera-
tions in its dynamics induced by chronic citalopram (cCIT).
FSCV is an electrochemical method with sufficient chemical
resolution necessary to identify serotonin (Hashemi et al,
2009), and sufficient temporal resolution to resolve the
processes of release from neuronal uptake (Hashemi et al,
2012). We have established that FSCV can monitor
serotonin release in vivo, specifically in the substantia nigra
pars reticulata (SNpr), which receives a dense serotonergic
projection from the dorsal raphe nucleus (DRN). Here, we
use FSCV to evaluate the effects of 20-day CIT exposure on
serotonin signaling in single-and pair-housed mice. We
found robust behavioral and neurochemical differences in
the effects of SSRI treatment between these groups.
MATERIALS AND METHODS
Animals
All experiments were performed in compliance with the
University of North Carolina at Chapel Hill (UNC) Institu-
tional Animal Care and Use Committee. Subjects were
C57BL/6J male mice (4–5 weeks in age and 20–27 g upon
arrival from Jackson Laboratory, Bar Harbor, ME), initially
housed in groups of four. After 1 week of acclimation,
40 mice were housed individually, and 36 mice were housed
in pairs. All subjects were kept on a 12-hour-day/light cycle
and given ad libitum access to food and water.
cCIT Treatment
To eliminate stress contribution from daily injections, CIT
hydrobromide (Roxane Laboratories) or vehicle (VEH) was
administered via water bottles for 20 days. Briefly, water
consumption was monitored for 7 days to establish a base-
line for each subject or pair of subjects. The concentration
of CIT added to water during the treatment period was
adjusted to 15 mg/kg/day (per oral) based on subject
weights and previous-day consumption volumes through-
out the treatment. CIT was obtained in a sweetened oral
solution formulation; therefore, VEH-treated animals received
water containing D-Sorbitol (1.68 g/5 ml; Sigma-Aldrich)
that matched the concentration in CIT solution. Using this
drug delivery method, individual differences in liquid
consumption are difficult to ascertain in pair-housed mice;
however, close inspection of drinking patterns in pair- vs
single-housed mice suggest no individual aberrations in
liquid consumption. Comparisons of overall consumption
can be found in Supplementary Figure 1A and B. On day 21,
treatment was discontinued, and mice were given bottles
containing only water. A 24-hour withdrawal period prior to
voltammetric experiments was selected based on pharma-
cokinetic analysis of CIT clearance in mice and implemen-
ted prior to voltammetric experiments in order to look at
the effects of cCIT treatment in absence of CIT (Fredricson
Overo, 1982).
Marble-Burying Assay
On day 21, 20 marbles were arranged in a 4 5 grid in a
(34 20.5 13.5 cm) cage containing 5 cm of bedding. Mice
were placed inside the cage for 30 min, after which the
number of buried marbles (o2/3 visible above bedding)
were counted.
Open Field Test
On day 21, 4–5 h after the marble-burying (MB) assay, mice
were evaluated for activity in an open field (OF) chamber
(41 41 30 cm) crossed by a grid of photobeams (Versa-
Max system, AccuScan Instruments). Counts were taken of
the number of photobeams broken during the trial in 5-min
intervals across 1 h, with separate measures for total
distance traveled, fine movements (repeated breaking of
the same set of photobeams), and rearing movements
(vertical activity). Time spent in the center region of the OF
was also recorded.
Detection of Evoked 5-HT Release
24 h after withdrawal from CIT or VEH solutions, mice were
evaluated for CIT-induced changes in electrically evoked
serotonin release, using previously described methods
(Hashemi et al, 2009). See Supplementary Methods for
more details.
Drugs and Reagents
CIT hydrobromide (obtained as oral solution, 10 mg/5 ml;
Roxane Laboratories) was diluted with water for chronic
treatment. CIT hydrobromide (for acute treatment), nomi-
fensine maleate salt, and urethane were dissolved in sterile
saline (0.9%). Intraperitoneal-injected drugs (for acute
treatments) were administered at a volume of 0.01 ml/g
body weight. All reagents were purchased from Sigma-
Aldrich (St Louis, MO) and used as received.
Data Analysis
Results are average values±SEM. Behavioral data were
analyzed using a two-way or repeated measures ANOVA
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with Bonferroni post hoc analyses. Trends in maximum
evoked amplitude ([5-HT]max) were analyzed using a
repeated measures ANOVA that compared the effects of
treatment between each housing group (single or pair),
using Sidak multiple comparisons post hoc analysis.
Release rate was calculated by fitting lines to the rising
phase of serotonin release for each stimulation frequency
(for each subject). To evaluate uptake, clearance half-life
(t1/2) was calculated in Clampfit (Molecular Devices, LLC,
USA) as the decay time between 100 and 50% evoked con-
centration for each subject and averaged. Because evoked
serotonin concentrations are significantly lower than the KM
for SERT (170 nM) (Shaskan and Snyder, 1970), Michaelis–
Menten kinetic analyses cannot provide unequivocal
distinctions of KM and Vmax. In instances where uptake is
unsaturated, it follows exponential, first-order decay, and
its half-life is therefore independent of peak concentration.
Moreover, t1/2 has been shown to highly correlate with
changes in apparent KM (Yorgason et al, 2011). Thus,
treating uptake as a first-order process characterized by t1/2
is the most appropriate analysis for these data. Increases
in this decay time reflect decreases in clearance rate. Net
overflow was calculated in Clampfit using the integral under
the curve for the first 15 s following the stimulation event
for each stimulation frequency (for each subject). Net overflow
analyses have also been shown to correlate well with kinetic
models of neurotransmitter release (Yorgason et al, 2011).
Groups were compared using a two-way ANOVA with
Tukey’s multiple comparisons post hoc analysis.
To verify whether evoked serotonin release was frequency-
dependent, [5-HT]max evoked at each stimulation frequency
was normalized within subjects to [5-HT]max evoked by
20 Hz stimulations. A line was fit to each group of norma-
lized values and a hypothesis test determined whether the
regression coefficient (slope) was significantly different
from zero. Treatment groups described as having fre-
quency-dependent release meet criteria by having a slope
that is significantly different from zero.
RESULTS
Electrical Stimulation of the DRN Evokes Serotonin
Release in the SNpr
To verify the chemical origin of signals measured using our
recording electrode coordinate, we tested the acute effects of
a norepinephrine/dopamine uptake inhibitor (nomifensine,
5 mg/kg, i.p.) and an SSRI (CIT, 10 mg/kg, i.p.) on evoked
release. In previous studies, a similar nomifensine dosage
had robust effects on dopamine signals but was low enough
to avoid nonselective effects (Robinson and Wightman,
2004). Likewise, the selected CIT dosage has been used with
robust results on serotonin signaling in prior studies (Hashemi
et al, 2012; Hashemi et al, 2009). Color plots and traces
show serotonin release at baseline (Figure 1a), unaltered
30 min after nomifensine (Figure 1b), and increased in
amplitude and t1/2 30 min after CIT (Figure 1c). This response
pharmacologically confirms that signals measured at
this location are serotonergic, without contribution from
catecholamines. Serotonin was also identified by its unique
cyclic voltammogram (Figure 1e) (Hashemi et al, 2009).
Representative histology shows the location of the stereo-
Figure 1 Voltammetric determination of serotonin release in the substantia nigra pars reticulata of the mouse brain. (a–c) Representative color plots (top)
and concentration vs time traces (bottom) showing electrically evoked serotonin release (a) prior to drug treatment, (b) 30 min after administration of
nomifensine (5 mg/kg, i.p.), and (c) 30 min after administration of citalopram (CIT, 10 mg/kg, i.p.). Traces were obtained from the oxidation current of
serotonin, indicated by the dotted white line on the color plots, at B0.8 V. (d) Representative histology from lesion showing targeted dorsoventral location
of recording electrodes in SNpr. Green, NeuN; Magenta, GFAP; Blue, 5-HT. Inset shows contralateral SNpr containing dense serotonergic terminals. (e)
Representative current–voltage trace taken at time point indicated by the dashed line in color plot C. (f) Timeline of experiments outlined in this paper: Mice
were transferred to single or pair housing 1 week prior to chronic CIT (cCIT) treatment. cCIT (15 mg/kg/day) or vehicle (VEH) was administered via water
bottles for 20 days. On day 21, marble-burying and open field assays were performed and animals were withdrawn from cCIT or VEH for 24 h. On day 22,
anaesthetized voltammetry experiments were performed. Data shown are means±SEM.
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taxic coordinate used for carbon-fiber electrode placement
(Figure 1d). Because electrolytic lesions from Nafion-coated
carbon-fiber microelectrodes are difficult to locate, we did
histology following electrolytic lesions with tungsten wires at
the same stereotaxic coordinate. Inset shows the contra-
lateral SNpr, illustrating its dense serotonergic terminal field.
Figure 1f illustrates the outline of experiments performed
in this work. Mice were moved from group housing to either
single or pair housing on Day 6, seven days prior to cCIT
treatment. During this time period, water consumption for
each mouse or pair of mice was monitored to establish the
concentration of CIT necessary in chronic treatment.
Addition of cCIT or VEH to water bottles began on Day 1
and was monitored and continually adjusted for weight
and prior-day consumption throughout 20 days of chronic
treatment. On Day 21, MB and OF assays were performed,
and cCIT and VEH treatments were replaced with water.
On Day 22, mice were anaesthetized and FSCV experiments
were performed.
Anxiety-Like Behavior is Reduced by cCIT Treatment
We selected the treatment period and dosage for cCIT based
on prior studies that used oral SSRI administration
and found robust neurochemical effects (Davidson and
Stamford, 1997, 2000). We used the MB assay, a standard
index of anxiety-like behavior, as previous studies had
found that chronic SSRI treatment in mice leads to
reductions in buried marbles (Arora et al, 2013; Ichimaru
et al, 1995). We also performed an OF test for CIT effects on
overall activity, as well as additional measures of anxiety-
like behavior (Jiao et al, 2011; Strekalova et al, 2013).
In line with previous reports (Arora et al, 2013; Ichimaru
et al, 1995), we found that cCIT decreased the number of
marbles buried (two-way ANOVA, main effect of treatment,
F(1,72)¼ 9.7, Po0.01) (Figure 2a). In post hoc analyses,
these effects of SSRI treatment were only significant in
paired-housed mice (Po0.05). In the OF test, cCIT did not
significantly affect general locomotion in either housing
group (Figure 2b and c), confirming previous findings
on CIT effects in C57BL/6 mice (Jiao et al, 2011;
Strekalova et al, 2013). However, cCIT led to highly
significant decreases in time spent in the center region of
the OF, in comparison with VEH (Figure 2d; main effect of
treatment, F(1,72)¼ 19.0, Po0.0001). cCIT also led to mild
reductions in fine movements, an index of repetitive and
stereotyped behavior (Figure 2e; main effect of treatment,
F(1,72)¼ 10.0, Po0.01). Rearing movements, another
measure of active exploration in the OF, were decreased
by cCIT (Figure 2e; main effect of treatment, F(1,68)¼ 9.5,
Po0.01), although this effect was only significant in
post hoc analyses when comparing VEH and cCIT treatment
Figure 2 Effects of cCIT or VEH treatment on MB and OF assays in pair- and single-housed mice. (a) Number of marbles (out of 20) buried during a
30 min marble-burying assay. (b and c) Distance traveled across a 60 min OF test. (d) Time spent in center of the OF chamber. (e) Fine movements during
OF testing. (f) Incidences of rearing during OF testing. Data shown are means±SEM. cCTI, chronic citalopram; OF, open field; MB, marble-burying;
VEH, vehicle. Bonferroni post hoc analysis: **Po0.01, *Po0.05.
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in the pair-housed mice (Po0.01). Overall, cCIT had
anxiolytic effects in the MB assay, but not in the OF test,
with more significant effects in the pair-housed mice.
cCIT Increases Serotonin Release in Pair-Housed Mice
Serotonin release exhibits robust dependence on stimula-
tion frequency when examined in brain slices (Dankoski
and Wightman, 2013). This is the result of uptake occurring
throughout stimulation pulse trains and has been described
using Michaelis–Menten models of neurotransmission
(Bunin et al, 1998; Dreyer et al, 2010). Table 1 compares
maximal release ([5-HT]max) evoked by a range of stimula-
tion frequencies (20–60 Hz, 60 pulses each). In marked
contrast to the slice results, we found that in vivo serotonin
signaling was not frequency-dependent under baseline
conditions. No significant effect of cCIT or frequency was
found when comparing [5-HT]max in VEH vs cCIT-treated
single-housed mice. However, cCIT increased [5-HT]max
in pair-housed mice compared with VEH-treated mice
(repeated measures ANOVA, main effect of treatment,
F(1,12)¼ 5.4, Po0.05), with main effects of stimulation
frequency (F(4,48)¼ 3.9, Po0.01), as well as a treatment
frequency interaction (F(4,48)¼ 5.9, Po0.001). Post hoc
analysis revealed significant differences at 50 and 60 Hz
(Po0.05).
After an acute CIT challenge (Table 1, bottom), the effects
of cCIT in pair-housed mice were maintained and inten-
sified (repeated measures ANOVA; main effect of treatment,
F(1,12)¼ 9.8, Po0.01; frequency, F(4,48)¼ 68.9, Po0.0001,
and treatment frequency interaction, F(4,48)¼ 7.6,
Po0.0001). Post hoc analyses revealed differences between
VEH and cCIT pair-housed mice at stimulus frequencies of
30 Hz, 40 Hz (both at Po0.05), 50 Hz, and 60 Hz (both at
Po0.01). Changes in [5-HT]max are not correlated with a
change in local serotonin content (Supplementary Figure
S1C). Therefore, functional changes in neurotransmission
must underlie the effects of cCIT treatment.
Increased [5-HT]max in cCIT Pair-Housed Mice is Due to
Facilitation of Release
To determine what underlies changes in [5-HT]max, we
analyzed the rate of release, clearance half-life (t1/2), and net
overflow in serotonin concentration traces evoked by 60 Hz,
1 s stimulations (Figure 3). Mice were withdrawn from CIT
or VEH for 24 h, sufficient to metabolize all remaining drug
(Fredricson Overo, 1982). Thus, serotonin release shown in
Figure 3 reflects baseline conditions and is not affected by
ongoing uptake inhibition. Figure 3a and b shows average
concentration traces of serotonin release at 60 Hz (concen-
tration traces for all stimulation frequencies are in Supple-
mentary Figure S2). cCIT treatment increased release rate
(two-way ANOVA, main effect of treatment F(1,25)¼ 6.1,
Po0.05), and there was an interaction between treatment
and housing (F(1,25)¼ 4.6, Po0.05) (Figure 3c). Post hoc
analysis revealed differences in 60 Hz release rate between
pair-housed VEH and cCIT mice (7.4±1.1 nM/s vs
19.2±3.1 nM/s, n¼ 6 and n¼ 8, respectively, Po0.01), but
not between single-housed VEH and cCIT mice.
Surprisingly, clearance (t1/2) of evoked serotonin was
unaltered by cCIT treatment in either housing group
(Figure 3d). This demonstrates that increases in [5-HT]max
(Table 1) were due to facilitation of release following cCIT
treatment. Similar results have been obtained in previous
voltammetric studies (Davidson and Stamford, 1997, 2000);
however, our result conflicts with the work of Benmansour
et al (1999), who found that baseline SERT function was
Table 1 Maximal [5-HT] Evoked by Stimulations Ranging in Frequency 20–60 Hz
20 Hz (nM) 30 Hz (nM) 40 Hz (nM) 50 Hz (nM) 60 Hz (nM)
Baseline
Single-housed
VEH (n¼ 6) 16.4±2.0 15.9±1.2 16.7±1.2 16.8±1.2 17.2±1.4
cCIT (n¼ 9) 22.3±2.6 20.4±1.8 20.8±2.7 21.5±2.3 21.9±2.0
Pair-housed
VEH (n¼ 6) 17.6±2.4 16.1±1.2 16.2±2.1 16.2±0.9 16.3±1.5
cCIT (n¼ 8) 21.8±2.7 26.1±3.6 29.3±4.9 32.3±4.9* 32.2±5.5*
Acute citalopram challenge
Single-housed
VEH (n¼ 6) 32.3±4.3 40.0±5.5 45.6±6.2 52.0±6.7 54.0±7.1
cCIT (n¼ 9) 37.2±7.2 44.9±8.4 49.5±8.9 53.9±8.7 54.9±8.5
Pair-housed
VEH (n¼ 6) 26.6±3.7 35.3±5.0 40.8±5.2 46.2±5.4 48.3±4.6
cCIT (n¼ 8) 54.1±7.1 68.0±8.3* 78.3±9.3* 87.4±10.7** 92.4±11.5**
Abbreviations: cCIT, chronic citalopram; VEH, vehicle.
Sidak multiple comparisons test.
cCIT and VEH-treated mice were compared within either single- or pair-housing groups using a repeated measures ANOVA with Sidak multiple comparisons post hoc
analysis. Starred values denote significant differences between the cCIT value and VEH value immediately above it. *Po0.05, **Po0.01.
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impaired by chronic SSRI treatment. Their study was
conducted in the hippocampus and measured SERT
function using high concentrations of exogenously applied
serotonin, critical differences that may explain this dis-
crepancy.
In the present study, cCIT increased net overflow
(Figure 3e, two-way ANOVA, F(1,25)¼ 6.6, Po0.05), and
post hoc analysis showed differences between VEH and cCIT
treatment in pair-housed (0.11±0.02 mM s vs 0.22±0.04 mM
s, n¼ 6 and n¼ 8, respectively, Po0.05) but not single-
housed mice. Taken together, these data show that facilita-
tion of serotonin release is a major contributor to the
enhanced serotonergic neurotransmission in pair-housed
cCIT mice, whereas uptake is unaffected.
Figure 3 Comparison of serotonin release and uptake evoked by electrical stimulation of the DRN. (a and b) Averaged concentration vs time traces of
serotonin release evoked by a 60 Hz, 60-pulse stimulation of the DRN. Shaded bar below trace indicates the duration of stimulation. (c) Mean rate of change
in [5-HT] during the rising phase of release evoked by 60 Hz, 60-pulse stimulation. (d) t1/2 of evoked serotonin following 60 Hz, 60-pulse stimulation. (e)
Mean net overflow (area under curve) following 60 Hz, 60-pulse stimulations. (f) Averages of normalized maximal release amplitudes evoked by 20–60 Hz
stimulations. Dotted lines show best-fit linear regressions for each treatment group. Data shown are means±SEM. Tukey’s multiple comparisons post hoc
analysis: **Po0.01, *Po0.05.
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Because differences in neurotransmission were only
apparent in release evoked by higher frequency stimula-
tions, we developed an assay to quantitatively establish
frequency dependence, described in Materials and Methods.
Only serotonin release in pair-housed cCIT mice met the
criteria for frequency dependence (Figure 3f; hypothesis test
for regression slope, F(1,38)¼ 14.4, Po0.001). Frequency-
dependent facilitation of serotonin release in pair-housed
mice is a major outcome of cCIT treatment.
Acute Uptake Inhibition Enhances Facilitation of
Serotonin Release in cCIT Pair-Housed Mice
The above analyses examined how cCIT treatment altered
baseline serotonin neurotransmission in the absence of
circulating CIT. To understand how cCIT treatment affects
serotonin signaling in the presence of CIT, we administered
an acute challenge dose of CIT (10 mg/kg i.p.) and compared
its effects on evoked serotonin concentrations in single- vs
pair-housed and VEH vs cCIT groups. Supplementary
Figure 3A-D compares serotonin concentration traces
within each group prior to drug administration (baseline)
and 30 min after acute CIT challenge dose (aCIT). In each
group, acute CIT treatment significantly enhanced evoked
serotonin in a manner that is qualitatively similar to
previous reports (Hashemi et al, 2012). Release rate, t1/2,
and net overflow were all increased by the acute CIT
challenge as expected.
It is interesting to directly compare serotonin signals
under the influence of circulating CIT in VEH- vs cCIT-
treated animals, as this condition approximates ongoing
CIT exposure during clinical antidepressant therapies. Figure 4
examines differences in serotonin signaling between VEH
and cCIT single- and pair-housed mice after 30 min after the
acute CIT challenge was administered. Differences in uptake
are evident when comparing average concentration traces
evoked by 60 Hz, 60-pulse stimulations (Figure 4a and b).
In all groups, t1/2 was increased by acute CIT challenge
compared with baseline values, but to a lesser extent in cCIT
mice (2-way ANOVA, main effect of treatment, F(1,25)¼
7.4, Po0.05) (Figure 4d). This finding concurs with
Benmansour et al (1999), who found that SERT function
was less responsive to uptake inhibitors after chronic SSRI
treatment.
Release rate was altered by cCIT treatment (F(1,25)¼ 6.1,
Po0.05) and there was an in interaction between treatment
and housing (F(1,25)¼ 4.6, Po0.05). Post hoc analysis
revealed differences in release rate between pair-housed
VEH and cCIT mice (14.3±2.5 nM s 1 vs 26.9±3.8 nM s 1,
n¼ 6 and n¼ 8, respectively, Po0.05) but not single-housed
VEH and cCIT mice (Figure 4c). Acute CIT also increased
net overflow in cCIT mice (main effect of treatment,
F(1,25)¼ 6.0, Po0.05), with significant main effect of
housing (F(1,25)¼ 4.50, Po0.05) and a treatment x housing
interaction (F(1,25)¼ 8.5, Po0.01) (Figure 4e). Post hoc
analysis of net overflow revealed differences between VEH
and cCIT in pair-housed mice (0.53±0.06 mM s vs 1.13±
0.15 mM s, n¼ 6 and n¼ 8, respectively, Po0.01) and also
between single- and pair-housed cCIT mice (0.57±0.09 mM
s vs 1.13±0.15 mM s, n¼ 9 and n¼ 8, respectively, Po0.01).
The overall increase in release rate and net overflow after
acute CIT was expected, owing to SSRI-induced reductions
in uptake (Wightman and Zimmerman, 1990). Consistent
with this, release rates measured in the various groups of
mice varied in proportion to the baseline release rates, and
differences were still only observed in pair-housed mice.
We used a hypothesis test to quantitatively confirm fre-
quency dependence following acute CIT. Frequency depen-
dence was determined for all groups (Figure 4f, hypothesis
test for regression slope; VEH-single, F(1,28)¼ 182.4,
Po0.0001; cCIT single, F(1,38)¼ 25.9, Po0.0001; VEH-
pair, F(1,28)¼ 96.2, Po0.0001; cCIT pair, F(1,43)¼ 84.5,
Po0.0001). Although all groups showed frequency depen-
dence following acute CIT, the magnitude of release at all
frequencies was much greater in cCIT-treated paired
animals (Table 1, bottom).
DISCUSSION
Though SSRIs are commonly prescribed to treat disorders
involving depression and anxiety, the mechanisms by which
these agents exert therapeutic effects are not clear. Prior
studies have examined how chronic SSRI treatment affects
the serotonin system, but this is the first to compare effects
of SSRI treatment on endogenous, in vivo release dynamics.
Furthermore, this study directly addresses the interaction
of social environment with serotonergic function in this
context. Here, we found distinct differences in the effects of
chronic SSRI treatment on serotonin signaling in single- vs
pair-housed mice. We describe a novel effect of this
treatment—the facilitation of serotonin signaling in a
frequency-dependent fashion—and the ability to attenuate
this outcome with concurrent social isolation.
Levels of neurotransmitter in the extracellular space are
determined by a dynamic equilibrium between release and
uptake (Dreyer et al, 2010). Previously, we reported that
disruptions of serotonergic equilibria can be fatal, and
release and uptake are both tightly controlled to maintain
this balance (Hashemi et al, 2012). Further evidence of this
control can be seen in Table 1 and Figure 3f: in vivo release
in VEH and single-housed cCIT-treated mice is insensitive
to the rate of stimulation. In brain slices, serotonin neurons
have the capacity for frequency-dependent release (Dankoski
and Wightman, 2013), likely because inhibitory feedback
from intact serotonergic neurons and other neuromodula-
tory systems are severed during slice preparation. Sponta-
neous serotonergic burst firing does occur during distinct
behavioral states (Gartside et al, 2000; Jacobs, 1991);
however, multiple inhibitory systems preserve the pace-
maker-like firing (1–5 Hz) of serotonergic neurons. For
instance, somatodendritic 5-HT1a autoreceptors profoundly
limit the firing rate of serotonergic neurons (Blier et al,
1998b), and the DRN also receives complex feedback from
prefrontal cortex (Celada et al, 2001).
Following cCIT treatment, [5-HT]max was frequency-
dependent in pair-housed mice (Table 1). Our analyses
showed that this was due to increases in release rate, not
changes in t1/2 (Figure 3c and d). Thus, cCIT increases the
responsiveness of serotonergic neurons to higher stimulation
frequencies. This could arise from 5-HT1a autoreceptor
desensitization, a process that is well documented following
chronic SSRI exposure and is a critical component of its
antidepressant effects (Celada et al, 2013; Ferres-Coy et al,
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2013). Indeed, Davidson and Stamford showed that chronic
paroxetine decreased autoreceptor function in the DRN,
leading to enhancement of serotonin signaling, consistent
with this proposed desensitization (Davidson and Stamford,
2000). Acute CIT administration results in rapid, reversible
internalization of DRN 5-HT1a autoreceptors (Riad et al,
2004). The frequency-dependent effect of acute CIT exposure,
such that observed in VEH-treated single- and pair-housed
mice in Figure 4f, is also due to the effects of CIT on
autoreceptors in the DRN (unpublished observations).
Frequency-dependent signaling in cCIT-treated, pair-housed
mice could arise from the suppression of autoreceptor
feedback and would be a functional consequence of their
desensitization. Even at low frequencies, cCIT substantively
enhanced release in pair-housed mice after the acute CIT
challenge. This indicates that during chronic treatment,
Figure 4 Comparison of electrically evoked serotonin release following acute CIT challenge. (a and b) Averaged concentration vs time traces of serotonin
release evoked by a 60 Hz, 60-pulse stimulation of the DRN 30 min after acute CIT. Shaded bar below trace indicates the duration of stimulation. (c) Mean
rate of change in [5-HT] during the rising phase of release evoked by 60 Hz, 60-pulse stimulation after acute CIT challenge. (d) Mean t1/2 of evoked serotonin
following 60 Hz, 60-pulse stimulations. (e) Mean net overflow following 60 Hz, 60-pulse stimulations. (f) Averages of normalized maximal release amplitudes
evoked by 20–60 Hz stimulations. Dotted lines show best-fit linear regressions for each treatment group. Data shown are means±SEM. Tukey’s multiple
comparisons post hoc analysis: **Po0.01, *Po0.05.
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baseline increases in release are intensified by ongoing
uptake inhibition and may occur at low (1–5 Hz) firing rates.
This increased release allows greater interaction of extra-
cellular serotonin with its postsynaptic targets.
It could be hypothesized that chronic mild stress experi-
enced by single-housed C57BL/6J mice would produce a
depressive phenotype and intensify the effects of cCIT
treatment when compared with VEH-treated counterparts.
Surprisingly, social isolation blocked cCIT-induced facilita-
tion of serotonin release, but did not induce changes in
VEH-treated mice. Many behavioral and neurochemical
effects of social isolation are correlated with an upregulation
of HPA axis activity, including brain-wide increases in CRF
and CORT levels (Backstrom and Winberg, 2013; Blanchard
et al, 2001). One week of social isolation is sufficient to
observe its anxiogenic effects (Conrad et al, 2011; Liu et al,
2013). This suggests that by the time the single-housed mice
in this study began cCIT or VEH treatment, they were
already experiencing consequences from the chronic mild
stress paradigm. C57BL/6J mice are a resilient strain, and
under ordinary conditions, these increases may not be
behaviorally or neurochemically significant (Voikar et al,
2005). However, chronic SSRI treatment increases negative
feedback to the HPA axis, reducing its function (Barden,
1996, 2004; Pariante and Miller, 2001). SSRI-induced
changes in HPA axis activity directly affect serotonergic
activity (Celada et al, 2001, 2004; Johnson et al, 2007; Kirby
et al, 2008). Isolation-induced increases in HPA axis
function could negate the opposing effects of chronic SSRI
exposure. Thus, social isolation and cCIT treatment may
work against each other so that serotonin signaling is not
altered in single-housed mice.
Our finding that cCIT led to significant reductions in MB
in the pair-housed, but not in the single-housed, mice
provides additional evidence for lower sensitivity to SSRI
effects with chronic social isolation (Figure 2a). Paradoxi-
cally, cCIT treatment had an anxiogenic effect in the OF test,
decreasing center time in both single- and pair-housed mice
(Figure 2d). SSRI treatments have variable effects on center
time in other rodent studies, raising questions about the
predictive validity of this measurement for anxiolytic effects
of antidepressants (Borsini et al, 2002). As another example,
environmental enrichment has also been shown to have
generally anxiolytic effects in mice, but anxiogenic effects
similar to ours are seen in the OF test (Branchi and Alleva,
2006; Whitaker et al, 2009). One interpretation is that these
decreases in center time may indicate an adaptive increase in
risk assessment, rather than enhanced anxiety. Thus, cCIT
treatment may increase the ability of both single- and pair-
housed mice to inhibit impulsive exploratory behaviors.
Plasticity in serotonergic function and its downstream
targets underlies the efficacy of SSRI therapies for depres-
sion and OCD (Blier and de Montigny, 1998a). However,
prior studies have not characterized the changes in endo-
genous serotonin dynamics that occur during the therapeutic
period of SSRI treatment. In this study, we used in vivo
measurements to show that 20-day cCIT treatment facil-
itates serotonin release in a frequency-dependent manner
without altering SERT function. Prior studies have shown
that autoreceptor desensitization occurs with the onset of
therapeutic effects. Here, we demonstrate a consequence of
this desensitization, revealing profound increases in evoked
terminal serotonin release at all frequencies, a major
mechanistic change that may contribute to the therapeutic
actions of SSRIs. The observation that individually housing
animals can entirely block this effect in both baseline and
challenge conditions indicates that ongoing stress during
SSRI treatment is an important variable in individual
outcomes. This work shows that plasticity in the serotoner-
gic system is sensitive to environmental stress, and this can
influence the effects of SSRI therapies.
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